FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and medicine and concerns method of improvement of pharmakinetic characteristics of peroral medication, directly metabolised by UGT1A1, of formula (I), which includes peroral introduction to mammal, which needs drug treatment, of combination of medication, or its pharmaceutically acceptable salt, and atasanavir, or its pharmaceutically acceptable salt.
EFFECT: improvement of pharmakinetic characteristics of medication.
13 cl, 2 dwg, 14 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF CARBOXAMIDE INHIBITORS OF HIV INTEGRASE, CONTAINING COMPOSITION WITH CONTROLLED RATE OF RELEASE | 2005 |
|
RU2382648C2 |
HETEROCYCLIC IMMUNOMODULATORS AS INHIBITOR OF IMMUNE RESPONSE CHECKPOINTS PDL1 | 2020 |
|
RU2824127C2 |
HIV-INHIBITING BICYCLIC PYRIMIDIN DERIVATIVES | 2005 |
|
RU2403254C2 |
AZAPEPTIDE DERIVATIVES | 2008 |
|
RU2448958C2 |
1,5,6-SUBSTITUTED 2-OXO-3-CYANO-1,6A-DIAZATETRAHYDROFLUORANTHENES | 2006 |
|
RU2389730C2 |
6,7,8,9-SUBSTITUTED 1-PHENYL-1,5-DIHYDROPYRIDO (3,2-b) INDOLE-2-ONES EFFECTIVE AS ANTIINFECTIOUS PHARMACEUTICAL AGENTS | 2005 |
|
RU2377243C2 |
5-SUBSTITUTED 1-PHENYL-1,5-DIHYDROPIRIDO[3,2-b]INDOLE-2-ONES AND ANALOGUES AS ANTI-VIRUS PREPARATIONS | 2005 |
|
RU2362776C2 |
HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES | 2005 |
|
RU2405778C2 |
COMBINED PRODUCTS CONTAINING TYROSINE KINASE INHIBITORS AND THEIR USE | 2013 |
|
RU2660354C2 |
ANTIVIRAL ALIPHATIC ESTER PRODRUGS OF TENOFOVIR | 2017 |
|
RU2759902C2 |
Authors
Dates
2010-11-10—Published
2005-12-02—Filed